Foundation Medicine and Bristol Myers Squibb Expand Collab on CDx Development
Foundation Medicine and Bristol Myers Squibb are developing the FoundationOne CDx as a companion diagnostic for repotrectinib.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
